Aura Biosciences
PublicAura Biosciences is now publicly traded
The data on this page reflects Aura Biosciences's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
VC Round
Nov 3, 2021
Total Funding Raised
$176.34M
Company Overview
Aura Biosciences operates in Healthcare/Wellness and is based in Boston, Massachusetts. It has raised $176.34M.
Aura Biosciences (NAS: AURA) is a biotechnology company focused on developing precision immunotherapies aimed at treating various solid tumors while preserving organ function.
Sector
Healthcare/Wellness
AI Layer
Non-AI
Aura Biosciences Comparables
Compare Aura Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vinci Pharmaceuticals | 38% |
For institutional investors. Book with your work email.
Aura Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 3, 2021 | ||||
| VC Round | Apr 2, 2019 | ||||
| VC Round | Dec 21, 2017 | ||||
| VC Round | Sep 29, 2016 | ||||
| VC Round | Mar 5, 2015 | ||||
VC Round | Aug 15, 2014 |
For institutional investors. Book with your work email.
Aura Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Arix Bioscience | VC Round |
| Bellco Capital | VC Round |
Aura Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.